 Mohamed Awad
Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 6 | 2024 | 137 | 2.330 |
Why?
| | Artificial Limbs | 8 | 2025 | 173 | 1.790 |
Why?
| | Surgical Wound Infection | 4 | 2024 | 283 | 1.110 |
Why?
| | Pain, Postoperative | 2 | 2019 | 233 | 1.050 |
Why?
| | Arthroplasty, Replacement, Knee | 4 | 2024 | 305 | 0.880 |
Why?
| | Antibiotic Prophylaxis | 1 | 2024 | 101 | 0.850 |
Why?
| | Fractures, Open | 1 | 2023 | 31 | 0.830 |
Why?
| | Spine | 1 | 2024 | 158 | 0.810 |
Why?
| | Osteonecrosis | 2 | 2020 | 22 | 0.800 |
Why?
| | Bisphosphonate-Associated Osteonecrosis of the Jaw | 2 | 2019 | 5 | 0.800 |
Why?
| | Arthroplasty, Replacement | 2 | 2019 | 37 | 0.770 |
Why?
| | Orthopedic Procedures | 3 | 2024 | 210 | 0.770 |
Why?
| | Bone Density Conservation Agents | 2 | 2020 | 70 | 0.770 |
Why?
| | Personal Protective Equipment | 1 | 2020 | 49 | 0.670 |
Why?
| | Communicable Disease Control | 1 | 2020 | 73 | 0.650 |
Why?
| | Mandibular Reconstruction | 1 | 2019 | 4 | 0.630 |
Why?
| | Pharmacogenomic Variants | 1 | 2019 | 35 | 0.630 |
Why?
| | Cytochrome P450 Family 3 | 1 | 2018 | 3 | 0.620 |
Why?
| | Drug Interactions | 2 | 2022 | 394 | 0.610 |
Why?
| | Pharmacogenomic Testing | 1 | 2019 | 61 | 0.610 |
Why?
| | Operating Rooms | 1 | 2020 | 115 | 0.610 |
Why?
| | Fibula | 1 | 2019 | 47 | 0.600 |
Why?
| | Free Tissue Flaps | 1 | 2019 | 54 | 0.580 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1717 | 0.560 |
Why?
| | Analgesics, Opioid | 3 | 2022 | 913 | 0.550 |
Why?
| | Pharmacogenetics | 1 | 2018 | 175 | 0.540 |
Why?
| | Orthopedics | 3 | 2024 | 135 | 0.520 |
Why?
| | Quality of Life | 2 | 2025 | 2704 | 0.490 |
Why?
| | Pandemics | 2 | 2022 | 1488 | 0.490 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 341 | 0.480 |
Why?
| | Femur | 4 | 2025 | 244 | 0.480 |
Why?
| | Coronavirus Infections | 1 | 2020 | 335 | 0.480 |
Why?
| | Walking | 5 | 2024 | 501 | 0.430 |
Why?
| | Osseointegration | 4 | 2025 | 56 | 0.370 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 373 | 0.350 |
Why?
| | Lower Extremity | 2 | 2025 | 404 | 0.350 |
Why?
| | Osteoclasts | 3 | 2020 | 42 | 0.340 |
Why?
| | Humans | 36 | 2025 | 129652 | 0.330 |
Why?
| | Bone Marrow | 2 | 2023 | 271 | 0.320 |
Why?
| | Length of Stay | 3 | 2024 | 1127 | 0.310 |
Why?
| | Diphosphonates | 2 | 2019 | 58 | 0.300 |
Why?
| | Hip Joint | 3 | 2024 | 158 | 0.290 |
Why?
| | Gait | 3 | 2024 | 280 | 0.270 |
Why?
| | Laparoscopy | 2 | 2022 | 451 | 0.260 |
Why?
| | Spectrin | 1 | 2024 | 14 | 0.230 |
Why?
| | Bone Cements | 1 | 2024 | 41 | 0.230 |
Why?
| | Surgical Drapes | 1 | 2024 | 2 | 0.220 |
Why?
| | Joints | 1 | 2025 | 100 | 0.220 |
Why?
| | Biomechanical Phenomena | 5 | 2025 | 764 | 0.220 |
Why?
| | Osteogenesis | 2 | 2023 | 175 | 0.220 |
Why?
| | Microfilament Proteins | 1 | 2024 | 129 | 0.220 |
Why?
| | Orthopedic Surgeons | 1 | 2024 | 25 | 0.210 |
Why?
| | Functional Laterality | 1 | 2024 | 222 | 0.210 |
Why?
| | Mechanotransduction, Cellular | 1 | 2024 | 111 | 0.210 |
Why?
| | Fracture Fixation | 1 | 2023 | 78 | 0.200 |
Why?
| | Extracellular Traps | 1 | 2023 | 46 | 0.200 |
Why?
| | Vancomycin | 1 | 2023 | 78 | 0.200 |
Why?
| | Tibia | 1 | 2024 | 170 | 0.200 |
Why?
| | Testicular Hydrocele | 1 | 2022 | 4 | 0.190 |
Why?
| | Stroke | 2 | 2021 | 1071 | 0.190 |
Why?
| | Collateral Ligaments | 1 | 2021 | 14 | 0.190 |
Why?
| | Pressure Ulcer | 1 | 2022 | 34 | 0.190 |
Why?
| | Receptors, Angiotensin | 1 | 2021 | 12 | 0.190 |
Why?
| | Hernia, Inguinal | 1 | 2022 | 35 | 0.190 |
Why?
| | Tooth Extraction | 2 | 2020 | 28 | 0.190 |
Why?
| | Meniscus | 1 | 2021 | 21 | 0.180 |
Why?
| | Probability | 1 | 2022 | 306 | 0.180 |
Why?
| | Social Media | 1 | 2024 | 137 | 0.180 |
Why?
| | Trigger Finger Disorder | 1 | 2020 | 6 | 0.180 |
Why?
| | Operative Time | 1 | 2021 | 124 | 0.180 |
Why?
| | Tissue Preservation | 1 | 2020 | 11 | 0.180 |
Why?
| | Blood Loss, Surgical | 1 | 2021 | 93 | 0.170 |
Why?
| | Knee Injuries | 1 | 2021 | 99 | 0.170 |
Why?
| | Respiratory Protective Devices | 1 | 2020 | 12 | 0.170 |
Why?
| | Carrier Proteins | 1 | 2024 | 743 | 0.170 |
Why?
| | Urinary Tract Infections | 1 | 2022 | 152 | 0.170 |
Why?
| | Jaw Diseases | 1 | 2020 | 4 | 0.170 |
Why?
| | Cell Differentiation | 4 | 2023 | 1902 | 0.170 |
Why?
| | Bone and Bones | 2 | 2020 | 299 | 0.160 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2021 | 140 | 0.160 |
Why?
| | Surgeons | 1 | 2024 | 261 | 0.160 |
Why?
| | Osteoarthritis, Knee | 1 | 2023 | 240 | 0.160 |
Why?
| | Teratoma | 1 | 2020 | 105 | 0.160 |
Why?
| | Polymorphism, Genetic | 1 | 2022 | 640 | 0.160 |
Why?
| | Peptide Hormones | 1 | 2019 | 11 | 0.160 |
Why?
| | Dipeptidyl Peptidase 4 | 1 | 2019 | 13 | 0.160 |
Why?
| | Cerebrovascular Circulation | 2 | 2019 | 226 | 0.160 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2019 | 203 | 0.160 |
Why?
| | Collagen Type I | 1 | 2019 | 119 | 0.150 |
Why?
| | Ovary | 1 | 2020 | 210 | 0.150 |
Why?
| | Perioperative Care | 1 | 2020 | 152 | 0.150 |
Why?
| | Bone Resorption | 1 | 2019 | 79 | 0.150 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 110 | 0.150 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 284 | 0.150 |
Why?
| | Bone Transplantation | 1 | 2019 | 83 | 0.150 |
Why?
| | Malnutrition | 1 | 2019 | 79 | 0.150 |
Why?
| | Jaw | 1 | 2018 | 24 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1368 | 0.140 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2018 | 33 | 0.140 |
Why?
| | Dementia, Vascular | 1 | 2017 | 20 | 0.140 |
Why?
| | Occupational Health | 1 | 2020 | 192 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 249 | 0.140 |
Why?
| | Physical Conditioning, Animal | 1 | 2019 | 229 | 0.140 |
Why?
| | Recovery of Function | 1 | 2021 | 642 | 0.140 |
Why?
| | Ischemic Preconditioning | 1 | 2017 | 40 | 0.140 |
Why?
| | Patient Safety | 1 | 2020 | 287 | 0.130 |
Why?
| | Preoperative Care | 1 | 2019 | 340 | 0.130 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 130 | 0.130 |
Why?
| | Nutritional Status | 1 | 2019 | 328 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2024 | 1501 | 0.130 |
Why?
| | Patient Readmission | 1 | 2022 | 667 | 0.130 |
Why?
| | Dendritic Cells | 1 | 2020 | 478 | 0.130 |
Why?
| | Cytokines | 3 | 2019 | 2017 | 0.130 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 375 | 0.130 |
Why?
| | Adult | 8 | 2025 | 35577 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 613 | 0.130 |
Why?
| | Homeostasis | 1 | 2020 | 611 | 0.130 |
Why?
| | Postoperative Complications | 3 | 2022 | 2483 | 0.130 |
Why?
| | Program Evaluation | 1 | 2020 | 875 | 0.120 |
Why?
| | Vascular Remodeling | 1 | 2017 | 192 | 0.120 |
Why?
| | Pain Management | 1 | 2018 | 327 | 0.120 |
Why?
| | Male | 13 | 2025 | 63682 | 0.120 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3083 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2020 | 490 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2020 | 522 | 0.110 |
Why?
| | Pediatrics | 1 | 2022 | 1052 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 341 | 0.110 |
Why?
| | Peptides | 1 | 2019 | 925 | 0.110 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1614 | 0.110 |
Why?
| | Arthroplasty | 2 | 2024 | 47 | 0.110 |
Why?
| | Amputees | 2 | 2025 | 82 | 0.100 |
Why?
| | Animals | 11 | 2024 | 35361 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 346 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 1001 | 0.100 |
Why?
| | Prosthesis Implantation | 2 | 2023 | 145 | 0.090 |
Why?
| | Mice | 7 | 2024 | 16937 | 0.090 |
Why?
| | Knee Joint | 2 | 2025 | 371 | 0.090 |
Why?
| | Biomarkers | 2 | 2019 | 3973 | 0.090 |
Why?
| | Female | 9 | 2025 | 68777 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2024 | 14518 | 0.090 |
Why?
| | Body Mass Index | 1 | 2019 | 2273 | 0.090 |
Why?
| | Imidazoles | 2 | 2021 | 234 | 0.080 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 84 | 0.070 |
Why?
| | Brain | 1 | 2019 | 2679 | 0.070 |
Why?
| | Wound Healing | 2 | 2020 | 306 | 0.070 |
Why?
| | United States | 2 | 2022 | 13903 | 0.070 |
Why?
| | Rats | 3 | 2021 | 5500 | 0.060 |
Why?
| | Middle Aged | 5 | 2025 | 31155 | 0.060 |
Why?
| | Inflammation | 3 | 2023 | 2736 | 0.060 |
Why?
| | Aged | 4 | 2025 | 22104 | 0.060 |
Why?
| | Osteocytes | 1 | 2024 | 27 | 0.060 |
Why?
| | Iodophors | 1 | 2024 | 3 | 0.060 |
Why?
| | Prosthesis-Related Infections | 1 | 2024 | 75 | 0.050 |
Why?
| | Foot | 1 | 2024 | 93 | 0.050 |
Why?
| | Postoperative Period | 1 | 2024 | 329 | 0.050 |
Why?
| | Weight-Bearing | 1 | 2024 | 162 | 0.050 |
Why?
| | Movement | 1 | 2025 | 269 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 50 | 0.050 |
Why?
| | Scandinavian and Nordic Countries | 1 | 2022 | 12 | 0.050 |
Why?
| | Glycosylation | 1 | 2023 | 150 | 0.050 |
Why?
| | Stress, Mechanical | 1 | 2024 | 467 | 0.050 |
Why?
| | Pain Measurement | 1 | 2025 | 506 | 0.050 |
Why?
| | Prosthesis Design | 1 | 2024 | 306 | 0.050 |
Why?
| | Inguinal Canal | 1 | 2022 | 10 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2022 | 54 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2024 | 248 | 0.050 |
Why?
| | Range of Motion, Articular | 1 | 2024 | 366 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2023 | 300 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2022 | 151 | 0.050 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2021 | 9 | 0.050 |
Why?
| | Iatrogenic Disease | 1 | 2022 | 54 | 0.050 |
Why?
| | Postural Balance | 1 | 2024 | 200 | 0.050 |
Why?
| | Menisci, Tibial | 1 | 2021 | 59 | 0.050 |
Why?
| | Cell Survival | 1 | 2024 | 1086 | 0.050 |
Why?
| | Mammals | 1 | 2023 | 271 | 0.050 |
Why?
| | Cell Membrane | 1 | 2024 | 732 | 0.040 |
Why?
| | Thiophenes | 1 | 2021 | 118 | 0.040 |
Why?
| | Time Factors | 2 | 2024 | 6556 | 0.040 |
Why?
| | Arthroscopy | 1 | 2021 | 207 | 0.040 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 147 | 0.040 |
Why?
| | Health Policy | 1 | 2022 | 353 | 0.040 |
Why?
| | Nutrition Assessment | 1 | 2019 | 85 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2548 | 0.040 |
Why?
| | Equipment Design | 1 | 2020 | 514 | 0.040 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2018 | 5 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2019 | 441 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 166 | 0.040 |
Why?
| | Edetic Acid | 1 | 2018 | 46 | 0.040 |
Why?
| | Molar | 1 | 2018 | 49 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2018 | 89 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 49 | 0.040 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 2018 | 85 | 0.040 |
Why?
| | Ultrasonography | 1 | 2021 | 716 | 0.040 |
Why?
| | Intervertebral Disc | 1 | 2018 | 39 | 0.040 |
Why?
| | Chelating Agents | 1 | 2018 | 68 | 0.040 |
Why?
| | Sulfonamides | 1 | 2021 | 496 | 0.040 |
Why?
| | Myelin Basic Protein | 1 | 2017 | 45 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2024 | 2871 | 0.040 |
Why?
| | Neutrophils | 1 | 2023 | 1205 | 0.030 |
Why?
| | Infant | 2 | 2022 | 9024 | 0.030 |
Why?
| | Maze Learning | 1 | 2017 | 104 | 0.030 |
Why?
| | Nitrites | 1 | 2017 | 83 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1838 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 170 | 0.030 |
Why?
| | Ligands | 1 | 2019 | 622 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 778 | 0.030 |
Why?
| | Pain | 1 | 2023 | 789 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2020 | 504 | 0.030 |
Why?
| | Angiography | 1 | 2017 | 195 | 0.030 |
Why?
| | Random Allocation | 1 | 2017 | 346 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 637 | 0.030 |
Why?
| | Regeneration | 1 | 2018 | 180 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 422 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2018 | 307 | 0.030 |
Why?
| | Incidence | 1 | 2022 | 2644 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2017 | 297 | 0.030 |
Why?
| | Actins | 1 | 2017 | 411 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 653 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2018 | 716 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 485 | 0.030 |
Why?
| | Cognition | 1 | 2021 | 1123 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2708 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2018 | 2406 | 0.020 |
Why?
| | MicroRNAs | 1 | 2019 | 678 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5420 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7133 | 0.020 |
Why?
| | Calcium | 1 | 2018 | 1213 | 0.020 |
Why?
| | Child | 2 | 2022 | 20883 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5066 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2391 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3408 | 0.020 |
Why?
| | Macrophages | 1 | 2017 | 1480 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 9765 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4063 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 5440 | 0.020 |
Why?
| | Child, Preschool | 1 | 2020 | 10517 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4925 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10230 | 0.010 |
Why?
| | Adolescent | 1 | 2020 | 20394 | 0.010 |
Why?
|
|
Awad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|